Is the thigh a good tirzepatide injection site?

The outer thigh is a licensed site: aim for the middle section of the front or outer thigh, roughly halfway between your knee and hip.
Rotate injection sites each week (thigh one week, abdomen the next, for example) to avoid skin changes at any single spot.
Pinching a small fold of skin before injecting can help if you have a leaner thigh, reducing the chance of an intramuscular injection.
Injection-site reactions (mild redness, itching, or firmness) are common and usually short-lived; persistent lumps or skin changes are worth mentioning to your prescriber.

The thigh is one of three licensed injection sites for tirzepatide, alongside the abdomen and upper arm. It works well for many people — the outer thigh offers a reasonably large, accessible area of subcutaneous fat — and the NHS medicines page for tirzepatide confirms all three sites are suitable. Tirzepatide (sold in the UK as Mounjaro) is a prescription-only medicine; a GPhC-registered prescriber assesses clinical suitability before treatment starts.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Technique, rotation and what to watch for when injecting tirzepatide into the thigh

Where exactly on the thigh should you inject tirzepatide?

The target zone is the front or outer thigh, not the inner thigh, where the skin is thinner and large blood vessels sit closer to the surface. Aim for the middle third of the thigh: roughly midway between your knee and your hip. That area typically has a good layer of subcutaneous fat, which is where tirzepatide needs to be delivered.

Sit down with your leg relaxed before you inject. A tense muscle makes the injection harder and slightly more uncomfortable. If your thighs are quite lean, pinch a small fold of skin gently between your fingers before pressing the KwikPen in, this creates a little distance between the skin surface and the muscle beneath.

For a full walkthrough of the injection steps specific to this site, the step-by-step guide to giving a tirzepatide injection in the thigh covers the process in detail. The Patient Information Leaflet inside every Mounjaro box also includes illustrated guidance, read it at least once even if you feel confident.

Does it matter which thigh you use, and how often should you switch?

A question our prescribers hear most weeks: does rotating between left and right count as proper site rotation? The short answer is no, not on its own. Rotating between left and right thigh helps a little, but the bigger benefit comes from moving between the three licensed sites altogether (thigh, abdomen, upper arm) over successive weeks.

Repeated injections into the same small area of skin can cause lipohypertrophy, a localised build-up of fatty tissue that feels firm or lumpy. Beyond the cosmetic aspect, it matters clinically: tirzepatide absorbed through changed skin tissue may not reach the bloodstream as predictably, which could affect how well the medicine works. A simple rotation pattern (thigh one week, abdomen the next, upper arm the week after) keeps any one spot from bearing the load every time.

If you prefer the thigh and want to use it more often, at least move around within the thigh itself: left outer thigh, then right outer thigh, varying the spot by a few centimetres each time. Never inject into skin that is red, bruised, or tender from a previous injection. More on the broader rotation principles is covered in the guide to where exactly to inject tirzepatide in the thigh.

What side effects are specific to the thigh site?

Injection-site reactions are among the most commonly reported effects of subcutaneous GLP-1 medicines. At the thigh these typically show up as mild redness, slight swelling, itching, or a small firm patch in the hours after injecting. Most settle within a day or two without any treatment needed.

Cleaning the skin beforehand with a fresh alcohol swab and letting it dry completely before injecting reduces the risk of irritation. Injecting cold medicine straight from the fridge can also cause more discomfort, leaving the pen at room temperature for 30 minutes before use often makes the injection noticeably gentler. Always check the Mounjaro SmPC for the permitted room-temperature window rather than guessing.

If you notice a persistent lump that does not resolve after a couple of weeks, skin dimpling, or any sign of infection (spreading redness, warmth, or discharge), contact your prescriber promptly. The MHRA's Yellow Card scheme is also there for reporting unexpected or serious reactions.

The broader side-effect picture for tirzepatide is predominantly gastrointestinal (nausea, constipation, indigestion) rather than site-specific. For a fuller picture of what to expect and how to manage it, the tirzepatide injection guide runs through the most common experiences week by week.

Is the thigh better or worse than the abdomen for tirzepatide?

There is no head-to-head clinical evidence showing that tirzepatide is absorbed significantly differently between the three licensed sites in the way that has been demonstrated for some older insulins. All three are considered equivalent for practical purposes in the prescribing guidance. The best site is the one you can access comfortably, inject accurately, and rotate away from the following week.

In practice, the abdomen is often the easiest to reach and tends to have more subcutaneous fat for most people, which is why it is frequently the default. The thigh is popular with people who find it easier to see what they are doing when seated, or who want to avoid the abdomen for personal reasons, and our dedicated page on the Mounjaro thigh injection site goes into further detail for anyone who plans to use this location regularly. The upper arm requires a bit more coordination unless someone else helps. All three are equally valid.

If you are thinking about starting Mounjaro and wondering about the practicalities of self-injecting, those questions are worth raising at consultation, a prescriber can talk through your individual circumstances. Cost is another practical question; the Mounjaro pricing page sets out what private treatment involves.

Tirzepatide is a prescription-only medicine and clinical suitability is assessed before every prescription is issued. If you are ready to explore whether it is appropriate for you, start your free consultation with our prescribers.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions